STUB1 and atrial fibrillation: With increasing evidence suggesting that pro-inflammatory cytokines serve as a critical biological link between clonal hematopoiesis and AF, it is reasonable to hypothesize that mitigating inflammation through targeted interventions within the CHIP-inflammation axis may reduce the risk of incident AF and its progression.